Soros Fund Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-14,933
Closed -$268K 446
2014
Q1
$268K Buy
+14,933
New +$268K ﹤0.01% 284